Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations with enhanced stability and bioavailability for administration of (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones

Formulations with enhanced stability and bioavailability for administration of (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones

US Patent 10098862 · Granted Oct 16, 2018

Estimated economic value: $747,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenz2024
Pharmaceutical formulation of arsenic trioxide2023
Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenz2022
Formulations for the treatment of pain2020
Methods and compositions for treatment of cancer2020
Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone2017
Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone2015
Compositions and methods for prevention and treatment of wounds2015
Formulations for the treatment of pain2014
Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkox2013
Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substitu2011
Biodegradable polymer blends for drug delivery1999